BioCryst Pharmaceuticals BCRX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's common stock, shares issued (in shares)?
- BioCryst Pharmaceuticals (BCRX) reported common stock, shares issued (in shares) of $254.01M in Q1 2026.
- How has BioCryst Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- BioCryst Pharmaceuticals's common stock, shares issued (in shares) increased by 21.4% year-over-year, from $209.21M to $254.01M.
- What is the long-term trend for BioCryst Pharmaceuticals's common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's common stock, shares issued (in shares) has grown at a 4.3% compound annual growth rate (CAGR), from $187.91M to $213.06M.